Literature DB >> 12756425

Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome.

Bill McCarberg1, Robert L Barkin, Julie A Wright, Terry A Cronan, Erik Groessl, Steven M Schmidt.   

Abstract

The object of this study was to determine the association between tender point pain ratings, tender point counts and distress in people with fibromyalgia and to review the pharmacotherapy of fibromyalgia. Demographic, psychosocial, and health status information was collected from 316 health maintenance organization members with fibromyalgia. A manual tender point exam was conducted. Tender point counts predicted 3.0%, and tender point severity ratings predicted 8.3%, of the variance in distress. Little difference was found between the variance predicted for physical versus psychologic distress. A principal components analysis of all measures produced four distinct factors: global-physical functioning, tender points, psychologic, and physical. Tender point pain ratings and counts predicted a small but significant amount of variance in distress. In addition, FMS involves at least four rather distinct factors, one of which is related to tender points. Pharmacotherapeutic management is provided on a patient-specific basis including pharmacokinetics, pharmacodynamic, pathophysiologic, and psychosocial needs designed and modulated for each individual patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756425     DOI: 10.1097/00045391-200305000-00005

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  4 in total

1.  Serum lipid profile in fibromyalgia women.

Authors:  Gulcan Gurer; Omer Faruk Sendur; Cavidan Ay
Journal:  Clin Rheumatol       Date:  2005-10-01       Impact factor: 2.980

2.  The relationship between tender point count and disease severity in patients with primary fibromyalgia.

Authors:  Ali Salli; Halim Yilmaz; Hatice Ugurlu
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

3.  Duloxetine for the management of fibromyalgia syndrome.

Authors:  Beth A Scholz; Cara L Hammonds; Chad S Boomershine
Journal:  J Pain Res       Date:  2009-07-21       Impact factor: 3.133

4.  Management of fibromyalgia syndrome: review of evidence.

Authors:  Akiko Okifuji; Bradford D Hare
Journal:  Pain Ther       Date:  2013-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.